Keyword: MannKind


Sanofi forgives MannKind's debt over failed Afrezza deal

It looks like Sanofi will go the "forgive and forget" route with jilted partner MannKind and its inhalable insulin Afrezza. It will forgive a boatload of debt tied to their original deal and forget it ever got into the relationship in the first place.